期刊文献+

维甲酸亚砷酸联合蒽环类药物治疗急性早幼粒细胞白血病的临床研究 被引量:5

Clinical study of all-trans retinoic acid,Arsenic Trioxide combined with anthracycline for newly diagnosed acute promyelocytic leukemia
下载PDF
导出
摘要 目的回顾性研究全反式维甲酸(all-trans retinoic aid,ATRA)和亚砷酸(ATO)联合蒽环类抗生素(anthracy-cline,ATC)诱导和巩固治疗初发急性早幼粒细胞白血病(acute promyelocytic leukemia,APL)的疗效及不良反应。方法对17例初治APL患者予ATRA和ATO联合ATC方案诱导化疗,达完全缓解(CR)后,以ATC、ATRA、ATO交替序贯巩固治疗,用巢氏逆转录聚合酶链式反应(reverse transcription polymerase chain reaction,RT-PCR)的方法检测PML-RARα融合基因,三次阴性者进入ATRA维持治疗。结果 17例患者中CR 16例(94.7%),中位巩固治疗时间12月(8~13月)。16例CR患者的中位血液学持续性完全缓解(CCR)时间58.1月(95%CI:48.6~67.8),中位分子生物学CCR时间为53.8月(95%CI:42.8~64.7)。17例患者的三年总生存(OS)率(94.1±5.7)%,五年OS率(78.4±15.1)%。达到CR的16例患者中,三年无病生存(DFS)率(93.8±6.1)%,五年DFS率(71.4±14.6)%。结论 ATRA及ATO联合ATC治疗初发APL患者CR率高,CCR时间长,住院治疗时间短,不良反应较小。定期监测融合基因有助于早期发现复发,提高疗效。 Objective To retrospectively analyze the clinical efficacy and side effect of all-trans retinoic acid(ATRA),ATO combined with anthracycline(ATC)as induction and consolidation regimens for newly diagnosed acute promyelocytic leukemia(APL).Methods Seventeen newly diagnosed APL patients were treated with ATRA and ATO combined with ATC as induction therapy.After complete remission,three cycles of consolidation therapy were given,with alternation of ATC,ATRA and ATO.When PML-RARα fusion genes were consistently negative for three times during consolidation,the patients were treated with ATRA every three months as maintenance therapy.Results Sixteen of 17 patients(94.7%)in this study achieved complete remission(CR).The median time of consolidation was 12 months(rang 8~13months).Among the sixteen cases who achieved CR,the median time of three-year hematological continuous complete remission(CCR)duration was 58.1(95%CI:48.6~67.8)months and three-year molecular genetic CCR duration was 53.8(95%CI:42.8~64.7)months.Three-year and 5-year overall survival rates were(94.1±5.7)% and(78.4±15.1)% respectively.Among the sixteen CR cases,three-year disease free survival(DFS)and 5-year DFS were(93.8±6.1)% and(71.4±14.6)%,respectively.Conclusions The treatment of ATRA,ATO combined with ATC has some advantages in high CR rates,prolonged CCR duration,shorted hospitalized time and few side effects.The sequential detection of nested RT-PCR for PML-RARα transcript could predict relapse and improve prognosis.
出处 《实用医院临床杂志》 2011年第4期14-17,共4页 Practical Journal of Clinical Medicine
关键词 急性早幼粒细胞白血病 维甲酸 亚砷酸 疗效 不良反应 蒽环类抗生素 Acute promyelocytic leukemia Retinoic acid Arsenious oxide Efficacy Side effect Anthracycline
  • 相关文献

参考文献17

  • 1Ghavamzadeh A,Alimoghaddam K.Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy[J].Ann Oncol,2006,17(1):131-134.
  • 2高晓东,胡炯.急性早幼粒细胞白血病的治疗[J].世界临床药物,2007,28(8):489-492. 被引量:7
  • 3Miguel A,Sanz C,Guillerm O,et al.Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy:a multicenter study by the PETHEMA group[J].Blood,2004,103:1237-1243.
  • 4张鹏,王树叶,胡龙虎,邱凤芹,杨惠芬,肖彧君,李晓霞,韩雪英,周晋,刘澎.三氧化二砷治疗急性早幼粒细胞白血病七年总结——附242例分析[J].中华血液学杂志,2000,21(2):67-70. 被引量:320
  • 5李新,赵耀中,李增军,李云涛,李妍,万长春,李桥川,邓书会,杨仁池,韩明哲,邱录贵.急性早幼粒细胞白血病170例长期生存分析[J].中国实验血液学杂志,2006,14(3):437-441. 被引量:18
  • 6Ikeda K,Sasaki K,Tasaka T,et al.PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome[J].Int J Hematol,1994,60(3):197-205.
  • 7Santamaria C,Chillon MC,Fernandez C,et a1.Using quantification of the PML-RARa transcript to stratify the risk of relapse in patients with acute promyelocytie leukemia[J].Haematologica,2007,92:315-322.
  • 8Esteve J,Escoda L,Martin G,et a1.Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with a11-trans retinoic acid and anthracycline-based chemotherapy(PETHEMA protocols LPA96 and LPA99):benefit of all early intervention[J].Leukemia,2007,2l:446-452.
  • 9Small D.FLT3 Mutations:biology and treatment hematology[C].Am Soc Hematol Educ Program,2006:178-184.
  • 10Kottaridis PD,Gale RE,Frew ME,et a1.The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia(AML)adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy:analysis of 854 patients from the United Kingdom Medical Research Council AML l0 and l2 trials[J].Blood,2001,98:l752-1759.

二级参考文献61

  • 1王莉红,周春林,张新伟,陈森,王敏,王建祥.FLT3基因内部串联重复突变与急性白血病的关系及临床意义[J].中华血液学杂志,2004,25(7):393-396. 被引量:35
  • 2孙爱宁,周海侠,吴德沛,王玮,金正明,仇惠英.急性早幼粒细胞白血病PML/RARα异型的临床意义[J].中国实验血液学杂志,2005,13(3):500-502. 被引量:8
  • 3王一,刘兵城,彭智,肖志坚.甲异靛对急性早幼粒细胞白血病细胞系NB_4体外作用的研究[J].白血病.淋巴瘤,2005,14(3):136-139. 被引量:5
  • 4王彤,王杰.白血病患者Flt-3基因突变检测及临床意义[J].中华血液学杂志,2006,27(11):766-767. 被引量:2
  • 5Yamamoto Y, Kiyoi H, Nakano Y, et al. Activating matation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 2001, 97: 2434-2439.
  • 6Whitman SP, Archer KJ, Feng L, et al. Absence of the wild-type allele predicts poor prognosis in adult denovo acute myelaid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res, 2001, 61 : 7233-7239.
  • 7Kottaridis PD, Gale RE, Frew ME, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council- AML10 and 12 trials. Blood, 2001, 98: 1752-1759.
  • 8Meshinchi S, Woods WG, Stirewalt DL, et al. Prevalence and prognostic significance of FUI3 internal tandem duplication in pediatric acute myeloid leukemia. Blood, 2001, 97: 89-94.
  • 9Bang SM, Ahn JY, Park J, et al. Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia. J Korean Med Sci, 2008, 23 : 833-837.
  • 10Natasa C, Natasa T, Sanja A, et al. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Ann Hematol, 2007, 86: 741-747.

共引文献441

同被引文献62

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部